A pharmaceutical company has recalled a blood pressure medication due to a potential cancer risk, the FDA announced this week.

Aurobindo Pharma USA, Inc. announced a voluntary recall of two lots of quinapril and hydrochlorothiazide tablets which are often prescribed for the treatment of hypertension to lower blood pressure. The recall is due to higher levels of nitrosamine present in the tablets.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.